Email This Article
Headlines & Perspectives
Moody's Places Amgen Debt on Review
By
Elizabeth Trotta
03/17/08 - 05:27 PM EDT
The ratings firm cites last week's FDA panel recommendation to further limit Aranesp's use.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
Find more premium investing ideas